title: Use of oral budesonide in the management of protein-losing enteropathy due to restrictive cardiomyopathy.
abstract: A 7-year-old male patient who had abdominal swelling and eyelid oedema was diagnosed with restrictive cardiomyopathy. His serum albumin level was 2.3 g/dl. Protein-losing enteropathy due to restrictive cardiomyopathy was diagnosed and oral budesonide was started. His serum albumin level began to rise and ascites and peripheric oedema disappeared. The patient underwent a successful cardiac transplantation and budesonide was stopped. After the heart transplantation, the albumin level decreased to 2.3 g/dl, and therefore it was restarted. When the serum albumin level increased, the budesonide dose was tapered and stopped in 1 month. Budesonide may be an effective drug in patients with protein-losing enteropathy due to heart failure.
authors.affiliation: Department of Paediatric Cardiology,Baskent University,Ankara,Turkey.
authors.forename: Hazım A
authors.initials: HA
authors.lastname: Gursu
authors.affiliation: Department of Paediatric Cardiology,Baskent University,Ankara,Turkey.
authors.forename: Birgul
authors.initials: B
authors.lastname: Varan
authors.affiliation: Department of Paediatric Cardiology,Baskent University,Ankara,Turkey.
authors.forename: Ilkay
authors.initials: I
authors.lastname: Erdogan
mesh_terms: D000284:Administration, Oral; D001201:Ascites / Q000188:drug therapy* / Q000209:etiology; D019819:Budesonide / Q000008:administration & dosage*; D002313:Cardiomyopathy, Restrictive / Q000150:complications / Q000601:surgery*; D002648:Child; D004487:Edema / Q000188:drug therapy* / Q000209:etiology; D005938:Glucocorticoids / Q000008:administration & dosage*; D016027:Heart Transplantation; D006801:Humans; D008297:Male; D011504:Protein-Losing Enteropathies / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D012709:Serum Albumin; D016896:Treatment Outcome
chemical_list: D005938:Glucocorticoids; D012709:Serum Albumin; D019819:Budesonide